Sponsor pipeline

Jazz Pharmaceuticals clinical trial pipeline

Get alerts when Jazz Pharmaceuticals's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.

Show 3 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
6
Phase 1/2
1
Phase 2
5
Phase 2/3
1
Phase 3
6
Phase 4
2
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 20

Epilepsy (7) · Breast Cancer (3) · Esophageal Cancer (3) · Gastric Cancer (3) · HER2-Positive Cancer (3) · Lung Cancer (3) · Colorectal Cancer (2) · Glioma (2) · Head & Neck Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2)

Get alerts when Jazz Pharmaceuticals's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free